GHDx
Published on GHDx (https://ghdx.healthdata.org)


Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England

General Info

Geography 
England
United Kingdom (GBR)
Coverage type 
Subnational
Time period covered 
January, 2020 - December, 2021
Data type
Scientific literature
Keywords 
Ischemic heart disease

Citation

Authors 
Whiteley WN, Ip S, Cooper JA, Bolton T, Keene S, Walker V, Denholm R, Akbari A, Omigie E, Hollings S, Di Angelantonio E, Denaxas S, Wood A, Sterne JAC, Sudlow C
Journal 
PLoS Med
Pages 
e1003926
Publication year 
2022
Suggested citation 
Whiteley WN, Ip S, Cooper JA, Bolton T, Keene S, Walker V, Denholm R, Akbari A, Omigie E, Hollings S, Di Angelantonio E, Denaxas S, Wood A, Sterne JAC, Sudlow C. Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England. PLoS Med. 2022; 19: e1003926.

Source URL:https://ghdx.healthdata.org/record/association-covid-19-vaccines-chadox1-and-bnt162b2-major-venous-arterial-or-thrombocytopenic#comment-0